© 2022 MJH Life Sciences and Drug Topics. All rights reserved.
© 2022 MJH Life Sciences™ and Drug Topics. All rights reserved.
August 10, 2022
The FDA has granted Emergency Use Authorization EUA of the Jynneos vaccine for pediatric patients
August 09, 2022
The latest guidance for when to administer the COVID-19 vaccine to patients aged 6 months and older.
July 21, 2022
Adults aged 18 and older are eligible to receive the vaccine.
July 05, 2022
Purchase follows FDA recommendation to include Omicron component in boosters.
June 23, 2022
The preferential recommendation is built on research and real-world data
June 22, 2022
The FDA approved the pneumococcal 15-valent conjugate vaccine for the prevention of invasive pneumococcal disease in infants and children.
June 17, 2022
The FDA announced the EUA of both Moderna and Pfizer-BioNTech COVID-19 vaccines for use in children aged 6 months and older.
June 15, 2022
The program administered 60 vaccines to patients referred by their primary care physicians.
A majority of survey respondents were willing to receive a COVID-19 vaccine.
June 07, 2022
If authorized, it will be the fourth COVID-19 vaccine available in the Untied States.